rts logo

Will Pacific Biosciences of California Inc (PACB) benefit from Wall Street bulls Calls?

Pacific Biosciences of California Inc (NASDAQ: PACB) is -77.27% lower on its value in year-to-date trading and has touched a low of $1.25 and a high of $14.55 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PACB stock was last observed hovering at around $1.93 in the last trading session, with the day’s gains setting it 0.3%.

Currently trading at $2.23, the stock is 37.06% and -23.34% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 26.32 million and changing 15.54% at the moment leaves the stock -68.66% off its SMA200. PACB registered -81.71% loss for a year compared to 6-month loss of -65.80%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -21.34% gain in the last 1 month and extending the period to 3 months gives it a -63.32%, and is 19.25% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.46% over the week and 16.20% over the month.

Pacific Biosciences of California Inc (PACB) has around 796 employees, a market worth around $607.36M and $200.43M in sales. Profit margin for the company is -148.13%. Distance from 52-week low is 78.40% and -84.67% from its 52-week high. The company has generated returns on investments over the last 12 months (-18.90%).

with sales reaching $42.99M over the same period.The EPS is expected to grow by 23.49% this year, but quarterly earnings will post -6.20% year-over-year.

Pacific Biosciences of California Inc (PACB) Top Institutional Holders

The shares outstanding are 267.74M, and float is at 259.67M with Short Float at 20.34%.

Pacific Biosciences of California Inc (PACB) Insider Activity

The most recent transaction is an insider purchase by Meline David W,the company’sDirector. SEC filings show that Meline David W bought 40,000 shares of the company’s common stock on Mar 06 ’24 at a price of $4.40 per share for a total of $0.18 million. Following the purchase, the insider now owns 40000.0 shares.

Pacific Biosciences of California Inc disclosed in a document filed with the SEC on Mar 04 ’24 that HENRY CHRISTIAN Osold a total of 14,177 shares of the company’s common stock. The trade occurred on Mar 04 ’24 and was made at $4.87 per share for $69056.0. Following the transaction, the insider now directly holds 2.6 million shares of the PACB stock.

Still, SEC filings show that on Mar 04 ’24, Van Oene Mark disposed off 9,186 shares at an average price of $4.87 for $44745.0. The insider now directly holds 1,668,826 shares of Pacific Biosciences of California Inc (PACB).

Related Posts